Area of research
Radiology, Nuclear Medicine and Imaging · Biomaterials
Research interest
Research interests include Radiopharmaceutical Chemistry and Applications, Nanoparticle-Based Drug Delivery, Medical Imaging Techniques and Applications, and Nanoplatforms for cancer theranostics.
Quantitative Tissue Pharmacokinetics and EPR Effect of AGuIX Nanoparticles: A Multimodal Imaging Study in an Orthotopic Glioblastoma Rat Model and Healthy Macaque
Development of a stress response therapy targeting aggressive prostate cancer
AGuIX<sup>®</sup> from bench to bedside—Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine
Targeting RAS-driven human cancer cells with antibodies to upregulated and essential cell-surface proteins
Imaging PD-L1 Expression with ImmunoPET
<sup>68</sup> Ga-Radiolabeled AGuIX Nanoparticles as Dual-Modality Imaging Agents for PET/MRI-Guided Radiation Therapy
<sup>68</sup>Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience
A reactivity-based [<sup>18</sup>F]FDG probe for in vivo formaldehyde imaging using positron emission tomography
Long-Term<i>in Vivo</i>Clearance of Gadolinium-Based AGuIX Nanoparticles and Their Biocompatibility after Systemic Injection
Caged [<sup>18</sup>F]FDG Glycosylamines for Imaging Acidic Tumor Microenvironments Using Positron Emission Tomography
Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment
Ultrasmall particles for Gd‐MRI and <sup>68</sup>Ga‐PET dual imaging
A Top‐Down Synthesis Route to Ultrasmall Multifunctional Gd‐Based Silica Nanoparticles for Theranostic Applications
X-ray-Induced Singlet Oxygen Activation with Nanoscintillator-Coupled Porphyrins
Functionalization of Small Rigid Platforms with Cyclic RGD Peptides for Targeting Tumors Overexpressing α<sub>v</sub>β<sub>3</sub>-Integrins
Bifunctional polypyridyl-Ru(ii) complex grafted onto gadolinium-based nanoparticles for MR-imaging and photodynamic therapy
Development of gadolinium based nanoparticles having an affinity towards melanin